ImmunoGen, Inc.
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…
Biotechnology
US, Waltham [HQ]
Balance Sheet
14 Sheets · Starting from 2022In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 137.00 | 217.00 | 180.00 | 213.00 | 165.00 | 313.00 | 287.00 | 198.00 | 294.00 | 295.00 | 235.00 | 355.00 | 348.00 | 348.00 | |
|
Current
|
117.00 | 191.00 | 180.00 | 194.00 | 142.00 | 278.00 | 245.00 | 176.00 | 267.00 | 262.00 | 176.00 | 293.00 | 275.00 | 275.00 | |
| Cash And Equivalents | 109.00 | 191.00 | 160.00 | 194.00 | 142.00 | 278.00 | 245.00 | 159.00 | 267.00 | 262.00 | 176.00 | 293.00 | 275.00 | 275.00 | |
| Assets | 137.00 | 217.00 | 180.00 | 213.00 | 165.00 | 313.00 | 287.00 | 198.00 | 294.00 | 295.00 | 235.00 | 355.00 | 348.00 | 348.00 | |
| Accounts Receivables (AR) | - - | -2.00 | 4.00 | - - | -1.00 | -3.00 | 4.00 | -7.00 | - - | - - | -5.00 | 7.00 | -8.00 | -8.00 | |
| Inventory | 1.00 | - - | 1.00 | - - | 2.00 | 2.00 | - - | 2.00 | 1.00 | -16.00 | -32.00 | -30.00 | 16.00 | -28.00 | |
| Short Term Investments | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Assets | 2.00 | 1.00 | 19.00 | 2.00 | 2.00 | 4.00 | 4.00 | 5.00 | 2.00 | 4.00 | 5.00 | 7.00 | 11.00 | 11.00 | |
|
Non Current
|
20.00 | 26.00 | 14.00 | 18.00 | 23.00 | 35.00 | 42.00 | 19.00 | 27.00 | 33.00 | 59.00 | 61.00 | 73.00 | 73.00 | |
| Property, Plant, Equipment (Net) | 16.00 | 13.00 | 11.00 | 10.00 | 14.00 | 16.00 | 22.00 | 19.00 | 14.00 | 12.00 | 22.00 | 19.00 | 14.00 | 14.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | 3.00 | 13.00 | 2.00 | 7.00 | 8.00 | 19.00 | 19.00 | -19.00 | 13.00 | 20.00 | 36.00 | 41.00 | 59.00 | 59.00 | |
| Liabilities | 35.00 | 77.00 | 96.00 | 91.00 | 89.00 | 278.00 | 368.00 | 351.00 | 312.00 | 283.00 | 311.00 | 265.00 | 193.00 | 193.00 | |
|
Current
|
13.00 | 14.00 | 16.00 | 19.00 | 21.00 | 35.00 | 60.00 | 55.00 | 55.00 | 70.00 | 77.00 | 122.00 | 121.00 | 121.00 | |
| Accounts Payable | 1.00 | - - | - - | 1.00 | - - | 3.00 | 2.00 | - - | - - | 2.00 | -1.00 | - - | 26.00 | 26.00 | |
| Short Term Debt | - - | - - | - - | - - | - - | 19.00 | 20.00 | - - | -8.00 | -11.00 | 2.00 | 5.00 | 4.00 | 4.00 | |
| Deferred Revenue | 4.00 | 3.00 | 3.00 | 1.00 | 2.00 | - - | 13.00 | - - | 1.00 | - - | - - | 29.00 | 13.00 | 13.00 | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 6.00 | 8.00 | 9.00 | 13.00 | 14.00 | 7.00 | 15.00 | 47.00 | 54.00 | 69.00 | 64.00 | 78.00 | 58.00 | 58.00 | |
|
Non Current
|
21.00 | 63.00 | 80.00 | 72.00 | 68.00 | 242.00 | 307.00 | 96.00 | 256.00 | 213.00 | 234.00 | 143.00 | 71.00 | 71.00 | |
| Long Term Debt | - - | - - | - - | - - | - - | - - | 100.00 | 96.00 | 2.00 | 2.00 | 23.00 | 18.00 | 11.00 | 11.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 24.00 | 21.00 | 15.00 | 15.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | -282.00 | - - | -2.00 | -70.00 | -23.00 | -18.00 | - - | -11.00 | |
| Other Non Current Liabilities | - - | - - | - - | - - | - - | - - | 182.00 | -96.00 | 163.00 | 202.00 | 107.00 | 62.00 | 23.00 | 34.00 | |
| Equity | 102.00 | 139.00 | 83.00 | 121.00 | 75.00 | 35.00 | -81.00 | -152.00 | -17.00 | 11.00 | -76.00 | 89.00 | 155.00 | 155.00 | |
| Stockholders' Equity | 102.00 | 139.00 | 83.00 | 121.00 | 75.00 | 35.00 | -81.00 | -152.00 | -17.00 | 11.00 | -76.00 | 89.00 | 155.00 | 155.00 | |
| Retained Earnings | -372.00 | -430.00 | -503.00 | -576.00 | -648.00 | -708.00 | -853.00 | -932.00 | -1,028.00 | -1,183.00 | -1,287.00 | -1,331.00 | -1,694.00 | -1,694.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | 1.00 | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -50.00 | -58.00 | -73.00 | -72.00 | -71.00 | -60.00 | -143.00 | -156.00 | -96.00 | -167.00 | -122.00 | -66.00 | -222.00 | -222.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 473.00 | 569.00 | 621.00 | 735.00 | 765.00 | 790.00 | 821.00 | 778.00 | 1,009.00 | 1,232.00 | -1.00 | -1.00 | 50.00 | -2.00 | |
| Loss Other Compr. Income | - - | - - | -33.00 | -37.00 | -42.00 | -47.00 | -50.00 | - - | - - | -39.00 | 1,211.00 | 1,421.00 | 1,796.00 | 1,849.00 |